January 12, 2007, Newsletter Issue #46: Bextra and the FDA

Tip of the Week

In view of the recent concerns over dangerous side effects of COX-2 selective drugs like Bextra, the FDA has mandated further studies. In addition, the FDA urges health care providers and patients to report adverse event information to FDA via the MedWatch program by phone (1-800-FDA-1088), or by fax (1-800-FDA-0178).

About LifeTips

Now one of the top on-line publishers in the world, LifeTips offers tips to millions of monthly visitors. Our mission mission is to make your life smarter, better, faster and wiser. Expert writers earn dough for what they know. And exclusive sponsors in each niche topic help us make-it-all happen.

Not finding the advice and tips you need on this Bextra Tip Site? Request a Tip Now!


Guru Spotlight
Byron White